LOS ANGELES, March 18, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and analytics and pet health industries, announced that it has achieved a record revenue quarter with...
KEY POINTS
“It’s been 50 years and 7 recessions with a perfect record,” Estrella says. “It’s impossible to be 100% sure about the future but I’d say the chances of a recession in the...
Stocks surged higher in a sudden move after the U.S. said it was delaying China tariffs until December on items including cellphones and some clothing. The U.S. also removed some items from the list of new tariffs...
The Fed is expected to cut its fed funds target rate by a quarter point Wednesday, in a move seen as preventative by economists.
Stocks fell on Friday as Wall Street concluded a wild week amid trade war fears and worries over the global economy.
The Dow Jones Industrial Average closed 90.75 points lower, or 0.3% at...
Stocks fell on Thursday as technology shares led a broad market decline. Investors also pored through the latest batch of corporate earnings results along with comments from the top European Central Bank official.
NEW YORK – Health care companies led stocks lower on Monday as investors waited for more details on reports that the U.S. and China are moving closer to a deal to resolve their costly trade dispute.
The sell-off was most pronounced...
Uptick Newswire Stock Day Podcast welcomed Applied Biosciences Corp. (APPB) (''the Company''), a diversified company focused on multiple areas of the medical, bioceutical and pet health industry.
The idea that the U.S.-China trade dispute could turn into something more is starting to become reality.
Investors had been expecting two straight quarters of negative earnings growth, known as an “earnings recession.”
- Advertisement -
